Literature DB >> 10993946

Expression of unglycosylated mutated prion protein facilitates PrP(Sc) formation in neuroblastoma cells infected with different prion strains.

Carsten Korth1, Kiyotoshi Kaneko1, Stanley B Prusiner1.   

Abstract

Prion replication involves conversion of the normal, host-encoded prion protein PrP(C), which is a sialoglycoprotein bound to the plasma membrane by a glycophosphatidylinositol anchor, into a pathogenic isoform, PrP(Sc). In earlier studies, tunicamycin prevented glycosylation of PrP(C) in scrapie-infected mouse neuroblastoma (ScN2a) cells but it was still expressed on the cell surface and converted into PrP(Sc); mutation of PrP(C) at glycosylation consensus sites (T182A, T198A) produced low steady-state levels of PrP that were insufficient to propagate prions in transgenic mice. By mutating asparagines to glutamines at the consensus sites, we obtained expression of unglycosylated, epitope-tagged MHM2PrP(N180Q,N196Q), which was converted into PrP(Sc) in ScN2a cells. Cultures of uninfected neuroblastoma (N2a) cells transiently expressing mutated PrP were exposed to brain homogenates prepared from mice infected with the RML, Me7 or 301V prion strains. In each case, mutated PrP was converted into PrP(Sc) as judged by Western blotting. These findings raise the possibility that the N2a cell line can support replication of different strains of prions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993946     DOI: 10.1099/0022-1317-81-10-2555

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  19 in total

1.  Glycosylation influences cross-species formation of protease-resistant prion protein.

Authors:  S A Priola; V A Lawson
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

2.  Cellular prion protein participates in amyloid-β transcytosis across the blood-brain barrier.

Authors:  Thorsten Pflanzner; Benjamin Petsch; Bettina André-Dohmen; Andreas Müller-Schiffmann; Sabrina Tschickardt; Sascha Weggen; Lothar Stitz; Carsten Korth; Claus U Pietrzik
Journal:  J Cereb Blood Flow Metab       Date:  2012-02-01       Impact factor: 6.200

3.  Separation of native prion protein (PrP) glycoforms by copper-binding using immobilized metal affinity chromatography (IMAC).

Authors:  Henrik Müller; Alexander Strom; Gerhard Hunsmann; Andreas W Stuke
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

4.  Conditional modulation of membrane protein expression in cultured cells mediated by prion protein recognition of short phosphorothioate oligodeoxynucleotides.

Authors:  Marcela Viviana Karpuj; Sagit Gelibter-Niv; Anat Tiran; Angelika Rambold; Jörg Tatzelt; Max Nunziante; Hermann M Schatzl
Journal:  J Biol Chem       Date:  2010-12-14       Impact factor: 5.157

5.  New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products.

Authors:  David A Kocisko; Gerald S Baron; Richard Rubenstein; Jiancao Chen; Salomon Kuizon; Byron Caughey
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  Prion diseases: dynamics of the infection and properties of the bistable transition.

Authors:  N Kellershohn; M Laurent
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

7.  Prion protein amyloid formation under native-like conditions involves refolding of the C-terminal alpha-helical domain.

Authors:  Nathan J Cobb; Adrian C Apetri; Witold K Surewicz
Journal:  J Biol Chem       Date:  2008-10-17       Impact factor: 5.157

8.  Glycan-controlled epitopes of prion protein include a major determinant of susceptibility to sheep scrapie.

Authors:  Mohammed Moudjou; Eric Treguer; Human Rezaei; Elifsu Sabuncu; Erdmute Neuendorf; Martin H Groschup; Jeanne Grosclaude; Hubert Laude; Erdi Neuendorf
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Incomplete glycosylation during prion infection unmasks a prion protein epitope that facilitates prion detection and strain discrimination.

Authors:  Hae-Eun Kang; Jifeng Bian; Sarah J Kane; Sehun Kim; Vanessa Selwyn; Jenna Crowell; Jason C Bartz; Glenn C Telling
Journal:  J Biol Chem       Date:  2020-06-08       Impact factor: 5.157

10.  Proteomic, genomic and translational approaches identify CRMP1 for a role in schizophrenia and its underlying traits.

Authors:  Verian Bader; Liisa Tomppo; Svenja V Trossbach; Nicholas J Bradshaw; Ingrid Prikulis; S Rutger Leliveld; Chi-Ying Lin; Koko Ishizuka; Akira Sawa; Adriana Ramos; Isaac Rosa; Ángel García; Jesús R Requena; Maria Hipolito; Narayan Rai; Evaristus Nwulia; Uwe Henning; Stefano Ferrea; Christian Luckhaus; Jesper Ekelund; Juha Veijola; Marjo-Riitta Järvelin; William Hennah; Carsten Korth
Journal:  Hum Mol Genet       Date:  2012-07-13       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.